This report aims to provide a comprehensive study of the global market for Track-and-Trace and Serialization for Drug.
Report Highlights:
(1) Global Track-and-Trace and Serialization for Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Track-and-Trace and Serialization for Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Track-and-Trace and Serialization for Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Track-and-Trace and Serialization for Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Track-and-Trace and Serialization for Drug segment by type and by application and regional segment by type and by application.
(6) Track-and-Trace and Serialization for Drug industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Track-and-Trace and Serialization for Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Track-and-Trace and Serialization for Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Track-and-Trace and Serialization for Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Cloud-based segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Biopharmaceutical has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Track-and-Trace and Serialization for Drug include SoftGroup, TraceLink, Infosys, Bosch Packaging, SAP, Axway and Xyntec Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Cloud-based
On-premise
By Applications, the market is segmented into:
Biopharmaceutical
Chemical Pharmaceutical
Key Players Driving the Market:
SoftGroup
TraceLink
Infosys
Bosch Packaging
SAP
Axway
Xyntec Inc
1 Market Overview
1.1 Product Overview and Scope of Track-and-Trace and Serialization for Drug
1.2 Global Track-and-Trace and Serialization for Drug Market Size and Forecast
1.3 China Track-and-Trace and Serialization for Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Track-and-Trace and Serialization for Drug Share in Global Market, 2018-2029
1.4.2 Track-and-Trace and Serialization for Drug Market Size: China VS Global, 2018-2029
1.5 Track-and-Trace and Serialization for Drug Market Dynamics
1.5.1 Track-and-Trace and Serialization for Drug Market Drivers
1.5.2 Track-and-Trace and Serialization for Drug Market Restraints
1.5.3 Track-and-Trace and Serialization for Drug Industry Trends
1.5.4 Track-and-Trace and Serialization for Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Track-and-Trace and Serialization for Drug Revenue by Company (2018-2023)
2.2 Global Track-and-Trace and Serialization for Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Track-and-Trace and Serialization for Drug Concentration Ratio
2.4 Global Track-and-Trace and Serialization for Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Track-and-Trace and Serialization for Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Track-and-Trace and Serialization for Drug Revenue by Company (2018-2023)
3.2 China Track-and-Trace and Serialization for Drug Track-and-Trace and Serialization for Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Track-and-Trace and Serialization for Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Track-and-Trace and Serialization for Drug Industry Chain
4.2 Track-and-Trace and Serialization for Drug Upstream Analysis
4.3 Track-and-Trace and Serialization for Drug Midstream Analysis
4.4 Track-and-Trace and Serialization for Drug Downstream Analysis
5 Sights by Type
5.1 Track-and-Trace and Serialization for Drug Classification
5.1.1 Cloud-based
5.1.2 On-premise
5.2 By Type, Global Track-and-Trace and Serialization for Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029
6 Sights by Application
6.1 Track-and-Trace and Serialization for Drug Segment by Application
6.1.1 Biopharmaceutical
6.1.2 Chemical Pharmaceutical
6.2 By Application, Global Track-and-Trace and Serialization for Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Track-and-Trace and Serialization for Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Track-and-Trace and Serialization for Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Track-and-Trace and Serialization for Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Track-and-Trace and Serialization for Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Track-and-Trace and Serialization for Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Track-and-Trace and Serialization for Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Track-and-Trace and Serialization for Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Track-and-Trace and Serialization for Drug Market Size Market Share
7.6 South America
7.6.1 South America Track-and-Trace and Serialization for Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Track-and-Trace and Serialization for Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Track-and-Trace and Serialization for Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.4.2 By Company, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.5.2 By Company, China Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.6.2 By Company, Japan Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.9.2 By Company, India Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Track-and-Trace and Serialization for Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 SoftGroup
9.1.1 SoftGroup Company Information, Head Office, Market Area and Industry Position
9.1.2 SoftGroup Company Profile and Main Business
9.1.3 SoftGroup Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.1.4 SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.1.5 SoftGroup Recent Developments
9.2 TraceLink
9.2.1 TraceLink Company Information, Head Office, Market Area and Industry Position
9.2.2 TraceLink Company Profile and Main Business
9.2.3 TraceLink Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.2.4 TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.2.5 TraceLink Recent Developments
9.3 Infosys
9.3.1 Infosys Company Information, Head Office, Market Area and Industry Position
9.3.2 Infosys Company Profile and Main Business
9.3.3 Infosys Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.3.4 Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.3.5 Infosys Recent Developments
9.4 Bosch Packaging
9.4.1 Bosch Packaging Company Information, Head Office, Market Area and Industry Position
9.4.2 Bosch Packaging Company Profile and Main Business
9.4.3 Bosch Packaging Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.4.4 Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.4.5 Bosch Packaging Recent Developments
9.5 SAP
9.5.1 SAP Company Information, Head Office, Market Area and Industry Position
9.5.2 SAP Company Profile and Main Business
9.5.3 SAP Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.5.4 SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.5.5 SAP Recent Developments
9.6 Axway
9.6.1 Axway Company Information, Head Office, Market Area and Industry Position
9.6.2 Axway Company Profile and Main Business
9.6.3 Axway Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.6.4 Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.6.5 Axway Recent Developments
9.7 Xyntec Inc
9.7.1 Xyntec Inc Company Information, Head Office, Market Area and Industry Position
9.7.2 Xyntec Inc Company Profile and Main Business
9.7.3 Xyntec Inc Track-and-Trace and Serialization for Drug Models, Specifications and Application
9.7.4 Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
9.7.5 Xyntec Inc Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Track-and-Trace and Serialization for Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Track-and-Trace and Serialization for Drug Market Restraints
Table 3. Track-and-Trace and Serialization for Drug Market Trends
Table 4. Track-and-Trace and Serialization for Drug Industry Policy
Table 5. Global Track-and-Trace and Serialization for Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Track-and-Trace and Serialization for Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Track-and-Trace and Serialization for Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Track-and-Trace and Serialization for Drug Manufacturers Product Type
Table 10. China Track-and-Trace and Serialization for Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Track-and-Trace and Serialization for Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Track-and-Trace and Serialization for Drug Upstream (Raw Materials)
Table 13. Global Track-and-Trace and Serialization for Drug Typical Customers
Table 14. Track-and-Trace and Serialization for Drug Typical Distributors
Table 15. By Type, Global Track-and-Trace and Serialization for Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Track-and-Trace and Serialization for Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Track-and-Trace and Serialization for Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Track-and-Trace and Serialization for Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2029
Table 22. SoftGroup Company Information, Head Office, Market Area and Industry Position
Table 23. SoftGroup Company Profile and Main Business
Table 24. SoftGroup Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 25. SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 26. SoftGroup Recent Developments
Table 27. TraceLink Company Information, Head Office, Market Area and Industry Position
Table 28. TraceLink Company Profile and Main Business
Table 29. TraceLink Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 30. TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 31. TraceLink Recent Developments
Table 32. Infosys Company Information, Head Office, Market Area and Industry Position
Table 33. Infosys Company Profile and Main Business
Table 34. Infosys Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 35. Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 36. Infosys Recent Developments
Table 37. Bosch Packaging Company Information, Head Office, Market Area and Industry Position
Table 38. Bosch Packaging Company Profile and Main Business
Table 39. Bosch Packaging Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 40. Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 41. Bosch Packaging Recent Developments
Table 42. SAP Company Information, Head Office, Market Area and Industry Position
Table 43. SAP Company Profile and Main Business
Table 44. SAP Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 45. SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 46. SAP Recent Developments
Table 47. Axway Company Information, Head Office, Market Area and Industry Position
Table 48. Axway Company Profile and Main Business
Table 49. Axway Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 50. Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 51. Axway Recent Developments
Table 52. Xyntec Inc Company Information, Head Office, Market Area and Industry Position
Table 53. Xyntec Inc Company Profile and Main Business
Table 54. Xyntec Inc Track-and-Trace and Serialization for Drug Models, Specifications and Application
Table 55. Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin, 2018-2023
Table 56. Xyntec Inc Recent Developments
List of Figure
Figure 1. Track-and-Trace and Serialization for Drug Picture
Figure 2. Global Track-and-Trace and Serialization for Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Track-and-Trace and Serialization for Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Track-and-Trace and Serialization for Drug Market Share of Global
Figure 5. Global Track-and-Trace and Serialization for Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Track-and-Trace and Serialization for Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Track-and-Trace and Serialization for Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Track-and-Trace and Serialization for Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Track-and-Trace and Serialization for Drug Industry Chain
Figure 10. Cloud-based
Figure 11. On-premise
Figure 12. By Type, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2029
Figure 14. Biopharmaceutical
Figure 15. Chemical Pharmaceutical
Figure 16. By Application, Global Track-and-Trace and Serialization for Drug Revenue, 2018-2029, US$ Million
Figure 17. By Application, Global Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2029
Figure 18. By Region, Global Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2029
Figure 19. North America Track-and-Trace and Serialization for Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 20. By Country, North America Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
Figure 21. Europe Track-and-Trace and Serialization for Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
Figure 23. Asia Pacific Track-and-Trace and Serialization for Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country/Region, Asia Pacific Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
Figure 25. South America Track-and-Trace and Serialization for Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, South America Track-and-Trace and Serialization for Drug Revenue Market Share, 2018-2023
Figure 27. Middle East & Africa Track-and-Trace and Serialization for Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. U.S. Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 29. By Company, U.S. Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 30. By Type, U.S. Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 31. By Application, U.S. Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 32. Europe Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, Europe Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 34. By Type, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 35. By Application, Europe Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 36. China Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, China Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 38. By Type, China Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 39. By Application, China Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 40. Japan Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, Japan Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 42. By Type, Japan Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 43. By Application, Japan Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 44. South Korea Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, South Korea Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 46. By Type, South Korea Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 48. Southeast Asia Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, Southeast Asia Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 50. By Type, Southeast Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 51. By Application, Southeast Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 52. India Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, India Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 54. By Type, India Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 55. By Application, India Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 56. Middle East & Asia Track-and-Trace and Serialization for Drug Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, Middle East & Asia Track-and-Trace and Serialization for Drug Market Share, 2018-2023
Figure 58. By Type, Middle East & Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 59. By Application, Middle East & Asia Track-and-Trace and Serialization for Drug Revenue Market Share, 2022 VS 2029
Figure 60. Research Methodology
Figure 61. Breakdown of Primary Interviews
Figure 62. Bottom-up Approaches
Figure 63. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|